Pharmacogenomic study-A pilot study of the effect of pharmacogenomic phenotypes on the adequate dosing of verapamil for migraine prevention.
Yi-Chieh ChenHan WangJayawant N MandrekarCarrie E RobertsonAmaal J StarlingFred M CutrerChia-Chun ChiangPublished in: The pharmacogenomics journal (2024)
We demonstrated a wide range of effective and tolerable verapamil doses used for migraine in a cohort with various pharmacogenomic phenotypes.